Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Cash & Current Investments: 2020-2024

Historic Cash & Current Investments for Biofrontera (BFRI) over the last 5 years, with Dec 2024 value amounting to $5.9 million.

  • Biofrontera's Cash & Current Investments rose 17.85% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.4 million, marking a year-over-year increase of 46.23%. This contributed to the annual value of $5.9 million for FY2024, which is 316.05% up from last year.
  • As of FY2024, Biofrontera's Cash & Current Investments stood at $5.9 million, which was up 316.05% from $1.4 million recorded in FY2023.
  • In the past 5 years, Biofrontera's Cash & Current Investments registered a high of $27.8 million during FY2022, and its lowest value of $1.4 million during FY2023.
  • Its 3-year average for Cash & Current Investments is $11.7 million, with a median of $5.9 million in 2024.
  • Per our database at Business Quant, Biofrontera's Cash & Current Investments plummeted by 94.88% in 2023 and then skyrocketed by 316.05% in 2024.
  • Biofrontera's Cash & Current Investments (Yearly) stood at $8.1 million in 2020, then surged by 203.02% to $24.5 million in 2021, then increased by 13.08% to $27.8 million in 2022, then plummeted by 94.88% to $1.4 million in 2023, then surged by 316.05% to $5.9 million in 2024.